Use of prebiotics for inflammatory bowel disease

8Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The relevance of diet in both the pathogenesis and the therapy of inflammatory bowel disease is an evolving science. Disturbance of intestinal microflora (dysbiosis) is putatively a key element in the environmental component causing inflammatory bowel disease. Prebiotics are among the dietary components used in an attempt to counteract dysbiosis. Such predominantly carbohydrate dietary components exert effects on the luminal environment by physicochemical changes through pH alteration, by production of short chain fatty acids and by selectively promoting putatively 'health-beneficial' bacteria. The present review elaborates on some of the background rationale and mechanisms on the use of prebiotics. Additionally, published animal and human trials are discussed. © 2005 Pulsus Group Inc. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Szilagyi, A. (2005). Use of prebiotics for inflammatory bowel disease. Canadian Journal of Gastroenterology. Pulsus Group Inc. https://doi.org/10.1155/2005/415698

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free